Genitourinary Cancer
News
Real-world results with checkpoint inhibitors found inferior to trial results
Data suggest real-world survival is worse than survival in clinical trials.
Conference Coverage
PET guidance for radiation therapy improves prostate cancer outcomes
Using PET as well as conventional imaging to guide postprostatectomy radiation therapy reduces the risk of treatment failure.
Conference Coverage
Single and multifraction SBRT found comparable for lung metastases
A single-fraction regimen and a four-fraction regimen netted essentially the same toxicity and oncologic outcomes at 1 year of follow-up.
News
‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients
The NCI-MATCH trial has led to new clinical trial benchmarks, according to the study chair.
Conference Coverage
Lower BP and better tumor control with drug combo?
News
Novel assay may better detect urothelial carcinoma
The UroCAD assay proved more sensitive than urine cytology.
Opinion
The scope of under- and overtreatment in older adults with cancer
News
Global stomach cancer deaths decline as colorectal cancer deaths stagnate, rise
Data suggest fewer people are dying from stomach cancer, but in some countries, the risk of colorectal cancer death is increasing or declining...
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
News
If PPIs are onboard, atezolizumab may not work for bladder cancer
Proton pump inhibitor use was associated with worse overall and progression-free survival among patients on atezolizumab.